
Centene Corporation CNC
$ 59.14
2.37%
Annual report 2025
added 02-17-2026
Country |
|
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NYSESPB |
Shares |
493 M |
Market Cap[1] |
$ 29.2 B |
EBITDA (LTM) |
$ 3.57 B |
P/E (LTM) |
19.34 |
P/S (LTM) |
0.2 |
EPS (LTM) |
2.74 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
CVS Health Corporation
CVS
|
$ 93.26 | -0.06 % | $ 118 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
NovoCure Limited
NVCR
|
$ 17.96 | 0.34 % | $ 2 B | Nasdaq Global Select Market,SPB | ||
|
Molina Healthcare
MOH
|
$ 184.14 | 1.58 % | $ 9.72 B | NYSE,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 388.47 | 1.57 % | $ 353 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 286.24 | 1.5 % | $ 75.4 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 307.95 | 1.41 % | $ 37.1 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.